Can Avatrombopag be taken long-term?
AvatrombopagisbyDova PharmaceuticalsDeveloped in20185Menstrual AmericaFDAAvatrombopag is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) scheduled to undergo surgery and for the treatment of adult patients with chronic immune thrombocytopenia.

Avatrombopag(Avatrombopag)Long-term use is generally not recommended. Long-term use may cause adverse reactions, such as fever, abdominal pain, nausea, headache, fatigue and peripheral edema, fatigue, contusions, nosebleeds, upper respiratory tract infections, joint pain, gum bleeding, etc. Patients need to follow the doctor's advice when taking avatrombopag, do not change the dose on their own, check the platelet count on time, and inform the doctor in time if a serious reaction occurs. Avatrombopag is taken orally once a day for 5 consecutive days with food. 5Recheck after 5 days and inform the doctor of platelet count in time.
Single dose10 mg (0.5 times the lowest approved dose) to 80 Avatrombopag exhibits dose-proportional pharmacokinetics at mg (1.3 times) of the highest recommended dose. The geometric mean maximum concentration of avatrombopag (%CV) in healthy subjects after taking 40 mg of avatrombopag was 166 (84%) ng/mL, time-The area under the concentration curve is extrapolated to infinity(AUC0-inf)< /span>4198Example(83%) ng.hr/mL.The pharmacokinetics of avatrombopag were similar in healthy subjects and people with chronic liver disease.
Laos and Bangladesh have generic drugs that are officially on the market. The specifications are 28 tablets. Each box is about 6100 to 9100. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)